Overdiagnosis and overtreatment of early detected prostate cancer
- PMID: 17364211
- PMCID: PMC1913182
- DOI: 10.1007/s00345-007-0145-z
Overdiagnosis and overtreatment of early detected prostate cancer
Abstract
Early detection of prostate cancer is associated with the diagnosis of a considerable proportion of cancers that are indolent, and that will hardly ever become symptomatic during lifetime. Such overdiagnosis should be avoided in all forms of screening because of potential adverse psychological and somatic side effects. The main threat of overdiagnosis is overtreatment of indolent disease. Men with prostate cancer that is likely to be indolent may be offered active surveillance. Evaluation of active surveillance studies and validation of new biological parameters for risk assessment are expected.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/ijc.1588', 'is_inner': False, 'url': 'https://doi.org/10.1002/ijc.1588'}, {'type': 'PubMed', 'value': '11774270', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11774270/'}]}
- de Koning HJ, Auvinen A, Berenguer Sanchez A et al (2002) Large-scale randomized prostate cancer screening trials: program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97(2):237–244 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1093/heapro/dah405', 'is_inner': False, 'url': 'https://doi.org/10.1093/heapro/dah405'}, {'type': 'PubMed', 'value': '15520039', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15520039/'}]}
- Lowe JB, Ball J, Lynch BM et al (2004) Acceptability and feasibility of a community-based screening programme for melanoma in Australia. Health Promot Int 19(4):437–444 - PubMed
-
- Van Iersel CA, de Koning HJ, Draisma G et al (2006) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer (in press) - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa060476', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa060476'}, {'type': 'PubMed', 'value': '17065637', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17065637/'}]}
- Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS (2006). Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355(17):1763–1771 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0197-2456(00)00099-4', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0197-2456(00)00099-4'}, {'type': 'PubMed', 'value': '11189685', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11189685/'}]}
- O’Brien B, Nichaman L, Browne JE, Levin DL, Prorok PC, Gohagan JK (2000) Prostate, lung, colorectal and ovarian cancer screening trial project team. coordination and management of a large multicenter screening trial: the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 21(Suppl 6):310S–328S - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical